QQQ   427.32 (-0.75%)
AAPL   181.56 (-0.41%)
MSFT   402.79 (-0.31%)
META   471.75 (-0.33%)
GOOGL   141.12 (+0.43%)
AMZN   167.08 (-1.43%)
TSLA   193.76 (-3.10%)
NVDA   694.52 (-4.35%)
NIO   5.96 (-2.93%)
AMD   165.69 (-4.70%)
BABA   73.15 (-1.03%)
T   16.92 (-0.29%)
F   12.26 (-0.33%)
MU   80.71 (+1.52%)
CGC   3.54 (-7.33%)
GE   148.62 (-0.36%)
DIS   109.44 (-1.94%)
AMC   4.67 (-3.52%)
PFE   27.60 (-0.07%)
PYPL   58.63 (-0.86%)
XOM   102.75 (-0.94%)
QQQ   427.32 (-0.75%)
AAPL   181.56 (-0.41%)
MSFT   402.79 (-0.31%)
META   471.75 (-0.33%)
GOOGL   141.12 (+0.43%)
AMZN   167.08 (-1.43%)
TSLA   193.76 (-3.10%)
NVDA   694.52 (-4.35%)
NIO   5.96 (-2.93%)
AMD   165.69 (-4.70%)
BABA   73.15 (-1.03%)
T   16.92 (-0.29%)
F   12.26 (-0.33%)
MU   80.71 (+1.52%)
CGC   3.54 (-7.33%)
GE   148.62 (-0.36%)
DIS   109.44 (-1.94%)
AMC   4.67 (-3.52%)
PFE   27.60 (-0.07%)
PYPL   58.63 (-0.86%)
XOM   102.75 (-0.94%)
QQQ   427.32 (-0.75%)
AAPL   181.56 (-0.41%)
MSFT   402.79 (-0.31%)
META   471.75 (-0.33%)
GOOGL   141.12 (+0.43%)
AMZN   167.08 (-1.43%)
TSLA   193.76 (-3.10%)
NVDA   694.52 (-4.35%)
NIO   5.96 (-2.93%)
AMD   165.69 (-4.70%)
BABA   73.15 (-1.03%)
T   16.92 (-0.29%)
F   12.26 (-0.33%)
MU   80.71 (+1.52%)
CGC   3.54 (-7.33%)
GE   148.62 (-0.36%)
DIS   109.44 (-1.94%)
AMC   4.67 (-3.52%)
PFE   27.60 (-0.07%)
PYPL   58.63 (-0.86%)
XOM   102.75 (-0.94%)
QQQ   427.32 (-0.75%)
AAPL   181.56 (-0.41%)
MSFT   402.79 (-0.31%)
META   471.75 (-0.33%)
GOOGL   141.12 (+0.43%)
AMZN   167.08 (-1.43%)
TSLA   193.76 (-3.10%)
NVDA   694.52 (-4.35%)
NIO   5.96 (-2.93%)
AMD   165.69 (-4.70%)
BABA   73.15 (-1.03%)
T   16.92 (-0.29%)
F   12.26 (-0.33%)
MU   80.71 (+1.52%)
CGC   3.54 (-7.33%)
GE   148.62 (-0.36%)
DIS   109.44 (-1.94%)
AMC   4.67 (-3.52%)
PFE   27.60 (-0.07%)
PYPL   58.63 (-0.86%)
XOM   102.75 (-0.94%)

Cocrystal Pharma (COCP) SEC Filings & 10K Form

$1.44
-0.13 (-8.28%)
(As of 02/20/2024 ET)

Recent Cocrystal Pharma SEC Filings

DateFilerForm TypeView
01/08/2024
7:00 AM
Cocrystal Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/04/2024
3:01 PM
Cocrystal Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/02/2024
8:53 AM
Cocrystal Pharma (Subject)
SABBY MANAGEMENT, LLC (Filed by)
Form SC 13G/A
12/21/2023
4:00 PM
Cocrystal Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/06/2023
7:00 AM
Cocrystal Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/04/2023
7:00 AM
Cocrystal Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/29/2023
7:00 AM
Cocrystal Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2023
7:15 AM
Cocrystal Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2023
7:01 AM
Cocrystal Pharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/31/2023
7:00 AM
Cocrystal Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2023
7:00 AM
Cocrystal Pharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/29/2023
11:15 PM
Cocrystal Pharma (Filer)
Form EFFECT
05/24/2023
3:31 PM
Cocrystal Pharma (Filer)
Form S-3/A
05/15/2023
7:00 AM
Cocrystal Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2023
7:00 AM
Cocrystal Pharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/24/2023
7:13 AM
Cocrystal Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/10/2023
7:30 AM
Cocrystal Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/04/2023
7:30 AM
Cocrystal Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/29/2023
7:00 AM
Cocrystal Pharma (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:COCP) was last updated on 2/20/2024 by MarketBeat.com Staff